Rosuvastatin (CAS 287714-41-4) Lipid-lowering Pharmaceutical API

Rosuvastatin (CAS 287714-41-4) is a potent statin-class lipid-lowering API, renowned for its exceptional ability to reduce low-density lipoprotein (LDL) cholesterol and regulate lipid metabolism. Its unique molecular structure selectively inhibits HMG-CoA reductase, a key enzyme in cholesterol biosynthesis, effectively lowering blood lipid levels while elevating beneficial high-density lipoprotein (HDL) cholesterol. This high-purity pharmaceutical raw material complies with strict international pharmacopoeial standards, ensuring consistent potency and stability for clinical formulation.

Widely utilized in cardiovascular drug development, it serves as a core ingredient for medications targeting hypercholesterolemia, dyslipidemia, and atherosclerotic cardiovascular diseases. Valued for its strong lipid-lowering efficacy, favorable safety profile, and ability to reduce cardiovascular event risks, it addresses critical unmet needs for patients with lipid metabolism disorders. Choose this trusted lipid-lowering API to develop high-quality formulations that protect cardiovascular health and improve long-term patient outcomes.